US2024019433A1PendingUtilityA1
Assays and methods for the diagnosis of post-streptococcal disorders
Assignee: QUEST DIAGNOSTICS INVEST LLCPriority: Dec 22, 2011Filed: Sep 25, 2023Published: Jan 18, 2024
Est. expiryDec 22, 2031(~5.4 yrs left)· nominal 20-yr term from priority
G01N 33/56944G01N 33/686G01N 33/6893G01N 2800/38G01N 2469/20G01N 2333/315G01N 33/564G01N 33/6854
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are methods for diagnosing a disease in a subject with a previous streptococcal infection by determining the presence or absence of one or more autoantibodies in a biological sample from the subject, wherein the one or more autoantibodies recognize an antigen from a protein selected from the group consisting of ELAVL2, ELAVL3, ELAVL4, Nova-1, Nova-2, Cdr1, Cdr2; and Cdr3. The presence of such autoantibodies is indicative of a positive diagnosis for a post-streptococcal disease such as PANDAS, post-GABHS glomerulonephritis, rheumatic fever, autism and Syndenham's chorea.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . A method for diagnosing a disease in a subject, said method comprising,
(a) determining the presence or absence of one or more autoantibodies in a biological sample from the subject with a previous Streptococcal infection, wherein the one or more autoantibodies recognize an antigen from a protein selected from the group consisting of ELAVL2, ELAVL3, ELAVL4, Nova-1, Nova-2, Cdr1, Cdr2, and Cdr3 and (b) identifying the subject as
(i) having a disease selected from the group consisting of PANDAS, post-GABHS glomerulonephritis, rheumatic fever, autism and Syndenham's chorea, when the presence of one or more antibodies is detected, or
(ii) not having one of said diseases caused by the Streptococcal infection when each of said antibodies is absent.
2 . The method of claim 1 , wherein at least one of the one or more autoantibodies is selected from the group consisting of anti-Hu, anti-Ri and anti-Yo.
3 . The method of claim 1 , wherein the protein is selected from the group consisting of Nova-1 and Nova-2.
4 . The method of claim 1 , wherein the protein is selected from the group consisting of Cdr1, Cdr2, and Cdr3.
5 . The method of claim 1 , wherein the disease is PANDAS.
6 . The method of claim 1 , wherein the subject is a human.
7 . The method of claim 1 , wherein the subject is a pediatric subject.
8 . The method of claim 1 , wherein the biological sample is selected from the group consisting of blood, serum, and plasma.Join the waitlist — get patent alerts
Track US2024019433A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.